MAR 11, 2016 08:14 AM PST

Macrophages Break Down Protective Barrier of Pancreatic Tumors

WRITTEN BY: Kara Marker
In 2016, the five-year survival rate for pancreatic cancer increased from seven to eight percent (American Cancer Society). Not a monumental increase, but scientists are still working on therapies to get the numbers even higher.

Scientists from the Abramson Cancer Center University of Pennsylvania School of Medicine, in their new preclinical study published in the journal Cancer Discovery, investigated the potential of macrophages to break down protective walls around pancreatic tumors, also known as their microenvironment. They found that sending certain signals to macrophages with an experimental immune therapy can be successful in influencing them to strip away the protective parts that pancreatic tumors use to evade the harsh chemicals of chemotherapies.
 


“We’ve learned how antibodies that target a cell surface molecule called CD40 work with the immune system to tear back that wall,” said study leader Gregory Beatty, MD, PhD. Plus, the same antibodies were found to actually enhance the effect of chemotherapy once the tumor’s defenses were stripped away.

The ACC study recently published followed a previous study by the same researchers. In 2011 they illustrated the ability of CD40 to prompt monocyte and macrophage populations to destruct the tumor microenvironment. However, until their newest study, the team couldn’t pinpoint the precise mechanism behind the connection between CD40 and the immune cells.

Their new study involved mouse models of pancreatic cancer, and they were able to identify two immune factors released after CD40 antibody treatment. The suspects are chemokine ligand 2 (CCL2) and interferon gamma. While CCL2 recruits macrophage tumor infiltration, interferon-gamma prompts macrophages to release enzymes called metalloproteinases, which degrade the “fibrotic scaffold” of the tumor microenvironment, the structure that protects the cancerous cells from destruction by chemotherapy.

The tag team effort of CCL2 and interferon-gamma, as a result of CD40 antibody stimulation, leads to fibrosis degradation, identified by the scientists as the final blow in breaking down the tumor defenses.

While this discovery is promising in the fight against pancreatic cancer, the research team also realized that the timing of CD40 treatment followed by chemotherapy is extremely critical: too soon and patients are at risk for a 30 percent mortality rate, and too late and the chemotherapy is ineffective. They found that the “sweet spot” for chemotherapy delivery is five days post-CD40 treatment, where they saw the treatment well-tolerated and tumor cells shrinking and dying.

“Macrophages can be very potent killers of cancer,” Beatty said. “Since keeping them out of tumors is a challenge, why not harness their recruitment?”
 

Source: University of Pennsylvania School of Medicine
 
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
MAY 24, 2018
Immunology
MAY 24, 2018
The Link Between Tuberculosis and Parkinson Disease
There might be a link between Tuberculosis (TB) and Parkinson’s according to a study published in The EMBO Journal. This link is related to the mecha...
MAY 24, 2018
Immunology
MAY 24, 2018
Brain and Gut Link in Multiple Sclerosis
Scientists have discovered a new molecular pathway connecting brain and gut that if learned how to control, may be able to treat Multiple Sclerosis and oth...
JUN 13, 2018
Health & Medicine
JUN 13, 2018
Insurance Denials Prevent Patients From Getting Hep C Medication
Some ads are running on television and in major magazines about drugs for hepatitis C, known as Hep C or HCV. Available in the United States since 2014, th...
JUL 04, 2018
Health & Medicine
JUL 04, 2018
Addressing the HIV/AIDS Issue in Miami
While there have been great strides in the fight against HIV infection and AIDS, the problem is not going away anytime soon. Science Magazine and PBS News ...
JUL 19, 2018
Videos
JUL 19, 2018
Hazmat Spill at Johns Hopkins
Biohazards are a common problem in any kind of scientific research, and if a spill of dangerous materials occurs, it can be deadly. Luckily, a recent spill...
AUG 25, 2018
Immunology
AUG 25, 2018
Maternal Depression Alters Mom and Baby's Immune Markers
Maternal depression alters stress and immune system biomarkers in children leading to social withdrawal and behavioral problems....
Loading Comments...